- Patent Title: Pharmaceutical composition containing a hyaluronic acid derivative
-
Application No.: US17276263Application Date: 2019-11-15
-
Publication No.: US11744899B2Publication Date: 2023-09-05
- Inventor: Chiaki Takahata , Naoya Yamashita , Naoko Kunii , Hirotaka Hoshi
- Applicant: SEIKAGAKU CORPORATION
- Applicant Address: JP Tokyo
- Assignee: SEIKAGAKU CORPORATION
- Current Assignee: SEIKAGAKU CORPORATION
- Current Assignee Address: JP Tokyo
- Agency: GREENBLUM & BERNSTEIN, P.L.C.
- Priority: JP 18215867 2018.11.16
- International Application: PCT/JP2019/044851 2019.11.15
- International Announcement: WO2020/101013A 2020.05.22
- Date entered country: 2021-03-15
- Main IPC: A61K47/61
- IPC: A61K47/61 ; A61K47/55 ; A61P19/02 ; A61K47/02 ; A61K47/10 ; A61K47/26 ; A61K47/40 ; A61K9/00 ; A61K9/08 ; A61M5/178

Abstract:
Provided is a method for suppressing the generation of diclofenac lactam from a compound represented by a formula (1) in the description, including allowing the compound of the formula (1) and a component (A) that is at least one type of compound selected from the group consisting of a nonionic surfactant, a hydroxyalkylated cyclodextrin, a C1 to C3 mono-alcohol, a C2 to C3 di-alcohol, a C3 to C6 tri-alcohol, a polyalkylene glycol, a γ-lactone, polyvinylpyrrolidone, a chlorogenic acid, and an alkyl sulfate ester, and salts thereof to coexist. A method for producing a pharmaceutical composition containing a compound represented by the formula (1) and a component (A), and a pharmaceutical composition which is a product produced thereby are also provided.
Public/Granted literature
- US20220016255A1 PHARMACEUTICAL COMPOSITION Public/Granted day:2022-01-20
Information query
IPC分类: